AnodyneWiki

Dexamethasone

Dexamethasone
Dexamethasone
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass392.50 g/mol [1]
AppearanceCrystals from ether [1]
Melting point504 to 507 °F (NTP, 1992) [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /hydrogen fluoride/. [1]
Solubilityless than 1 mg/mL at 77 °F (NTP, 1992) [1]
Predicted LogP1.9 [1]
Structural Identifiers
[]
Molecular formulaC22H29FO5
IUPAC name(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
SMILESC[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C
InChIInChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1
InChIKeyUREBDLICKHMUKA-CXSFZGCWSA-N
CAS number50-02-2
UNII7S5I7G3JQL
PubChem CID5743
Pharmacokinetics[]
Elimination half-lifebiological half-life: 36–54 hours; plasma half-life: 4–5 hours[3][4]
MetabolismLiver
ExcretionUrine (65%)
Routes of administrationBy mouth, intravenous, intramuscular, subcutaneous, intraosseous, intravitreal, eye drop

Dexamethasone (also known as Decadron, Aeroseb-Dex, Cortisumman, Calonat, Decaderm, Dexacortal, Dexacortin, Prednisolone F, Fluormethylprednisolone or Δfluorene).

Chemistry

 []

Dexamethasone is a single defined stereoisomer.

Dexamethasone matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation. Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days. Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10. Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive. High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / induction / inhibition2522 (27 contraindicated)
shared target42

Medical side effects []

125 side effects listed on drug labels in (dexamethasone).

  • Abdominal distension
  • Abdominal pain
  • Gastrointestinal pain
  • Abscess
  • Pancreatitis acute
  • Amenorrhoea
  • Angioedema
  • Decreased appetite
  • Anxiety
  • Arthralgia
  • Musculoskeletal discomfort
  • Myalgia
  • Blister
  • Dermatitis bullous
  • Hypertrophic cardiomyopathy
  • Delusion
  • Dermatitis atopic
  • Diabetes mellitus
  • Diarrhoea
  • Dizziness
  • Dyspepsia
  • Ecchymosis
  • Epilepsy
  • Oesophagitis
  • Exophthalmos
  • Eye infection
  • Eye infection viral
  • Asthenia
  • Fatigue
  • Body temperature increased
  • Glaucoma
  • Hallucination
  • Headache
  • Cardiac failure congestive
  • Myocardial rupture
  • Haemorrhage
  • Haemoglobin
  • Herpes simplex
  • Hiccups
  • Hirsutism
  • Hyperglycaemia
  • Hypersensitivity
  • Hypertension
  • Hypocalcaemia
  • Hypotension
  • Inflammatory bowel disease
  • Irritability
  • Arthropathy
  • Osteoarthritis
  • Lethargy
  • Leukocytosis
  • Polymorphonuclear leukocytosis
  • Low birth weight baby
  • Muscle atrophy
  • Myocardial infarction
  • Acute coronary syndrome
  • Nausea
  • Necrosis ischaemic
  • Osteonecrosis
  • Aseptic necrosis
  • Opportunistic infection
  • Osteoporosis
  • Pancreatitis
  • Optic neuritis
  • Papilloedema
  • Peptic ulcer
  • Petechiae
  • Retinopathy of prematurity
  • Schizophrenia
  • Convulsion
  • Telangiectasia
  • Embolism
  • Embolism venous
  • Tuberculosis
  • Erythema
  • Urticaria
  • Angiopathy
  • Vasculitis
  • Vertigo
  • Vomiting
  • Weight increased
  • Weight decreased
  • Alkalosis hypokalaemic
  • Cataract
  • Skin atrophy
  • Growth retardation
  • Impaired healing
  • Intracranial pressure increased
  • Muscular weakness
  • Tendon rupture
  • Skin striae
  • Menstruation irregular
  • Nerve injury
  • Skin hyperpigmentation
  • Leukoderma
  • Malaise
  • Discomfort
  • Feeling abnormal
  • Ill-defined disorder
  • Increased appetite
  • Intraocular pressure increased
  • Euphoric mood
  • Cataract subcapsular
  • Posterior subcapsular cataract
  • Increased insulin requirement
  • Steroid withdrawal syndrome
  • Skin exfoliation
  • Oesophageal candidiasis
  • Spinal compression fracture
  • Myopathy
  • Proximal myopathy
  • Drug dependence
  • Atrophy
  • Cognitive disorder
  • Mania
  • Electrolyte imbalance
  • Scleral thinning
  • Increased tendency to bruise
  • Suicidal ideation
  • Neuropathy peripheral
  • Carbohydrate tolerance decreased
  • Pain
  • Hyperhidrosis
  • Insomnia
  • Paraesthesia

Indications

  • Acute leukaemia
  • Addison's disease
  • Adrenal insufficiency
  • Adrenocortical insufficiency acute
  • Anterior ischemic optic neuropathy
  • Asthma chronic
  • Blood disorder
  • Brain neoplasm
  • Cerebrovascular accident
  • Chorioretinitis
  • Colitis ulcerative
  • Collagen disorder
  • Conjunctivitis allergic
  • Corneal ulcer marginal
  • Cutaneous sarcoidosis
  • Dermatitis
  • Dermatitis contact
  • Dermatitis exfoliative
  • Dermatomyositis
  • Edema cerebral
  • Endocrine disorder
  • Enteritis
  • Erythema multiforme
  • Eye disorder
  • Gastrointestinal disorder
  • Giant cell arteritis
  • Haemolytic anaemia
  • Hypercalcaemia
  • Infection
  • Keratitis
  • Laryngitis
  • Laryngospasm
  • Leukaemia
  • Lichen simplex chronicus
  • Lung disorder
  • Lymphoma
  • Neoplasm
  • Neoplasm malignant
  • Neurodermatitis
  • Oedema
  • Optic neuritis
  • Osteoarthritis
  • Pemphigus
  • Polyarteritis nodosa
  • Psoriasis
  • Respiratory insufficiency
  • Rheumatic heart disease
  • Rheumatism
  • Rheumatoid arthritis
  • Sarcoidosis
  • Seborrhoeic dermatitis
  • Secondary adrenocortical insufficiency
  • Shock
  • Skin disorder
  • Status asthmaticus
  • Systemic lupus erythematosus
  • Thrombocytopenic purpura
  • Trauma
  • Ulcer

Experience reports

Erowid

There are currently 1 experience reports involving dexamethasone on : []

 []

  • Australia: Dexamethasone is a Schedule 4.[5]
  • Canada: Dexamethasone is Prescription only.
  • United Kingdom: Dexamethasone is Prescription only.
  • United States: Dexamethasone is Prescription only.[6][7][8]
  • European Union: Dexamethasone is Prescription only.[9][10]
  • Other: Dexamethasone is a Rx-only.

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5743, Dexamethasone. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5743
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Dexamethasone. UNII: 7S5I7G3JQL. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/7S5I7G3JQL
  3. Dogra P, Vijayashankar NP. Dexamethasone Suppression Test. StatPearls. 14 September 2020. PMID 31194457.
  4. Jobe AH, Milad MA, Peppard T, Jusko WJ. Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India. Clinical and Translational Science. March 2020; 13(2):391–99. PMID 31808984. https://doi.org/10.1111/cts.12724
  5. Dexamethasone Juno (Juno Pharmaceuticals Pty Ltd). Department of Health and Aged Care. https://www.tga.gov.au/resources/prescription-medicines-registrations/dexamethasone-juno-juno-pharmaceuticals-pty-ltd
  6. Ozurdex- dexamethasone implant. DailyMed. 30 October 2020. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b204f44-6e8a-4d17-803c-268f0b04679f
  7. Dexamethasone sodium phosphate solution/ drops. DailyMed. 31 July 2020. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6bdcefbe-51e3-4ca4-afda-5aeca7b6fa73
  8. Dexycu- dexamethasone injection, suspension. DailyMed. 20 December 2021. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=583d70ed-bc42-465b-983d-c770db58406f
  9. Ozurdex EPAR. European Medicines Agency (EMA). 17 September 2018. https://www.ema.europa.eu/en/medicines/human/EPAR/ozurdex
  10. Neofordex EPAR. European Medicines Agency (EMA). 25 July 2014. https://www.ema.europa.eu/en/medicines/human/EPAR/neofordex

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 19:01:13
drugspromissing (no DrugsPRO reagent data)2026-11-20 19:01:09
erowidok2026-11-20 19:01:11
gsrsok2026-11-20 19:01:10
hmdbmissing (hmdb.ca refused automated access to HMDB0015364)2026-11-20 19:01:09
keggok2026-11-20 19:01:15
pubchemok2026-11-20 19:01:08
redditmissing (no r/tripreports posts mention it)2026-11-20 19:01:09
siderok2026-11-20 19:01:09
structureok2026-11-20 19:01:09
wikipediaok2026-11-20 19:01:09